Contact us

DAY 2

May 21st, 2026 | Munich, Germany

Registration Time

08:00 AM - 08:45 AM

Chairperson Address

08:45 AM - 09:00 AM

Keynote 1

09:00 AM - 09:25 AM

Streamlined Biosimilar Development

Prof. Dr. med. Jens Heyn

Senior Global Clinical Development Manager
Sandoz

Keynote 2

09:25 AM - 09:50 AM

AI in Drug Development: From Hype to Decisions — What It Takes to Make It Work

Debarshi Dey

VP, Head of Data Science
Galapagos

Keynote 3

09:50 AM - 10:15 AM

AI governance in clinical Trials

Olena Goloborodko

Director
Zug Pharma

KEYNOTE 4

10:15 AM - 10:40 AM

10:15 AM
-
10:40 AM

Using Real-World Data to Optimize Drug Development in Oncology

  • Not all Real World Data is created equal: Understanding sources and differences in usability
  • How to use Real World Data in Drug Development and beyond
  • Aligning RWD/RWE with Regulatory Expectations across Different Jurisdictions

Michael Pröschel

Chief Executive Officer
iOMEDICO

IO

iOMEDICO

COFFEE BREAK

10:40 AM - 10:45 AM

NETWORKING SESSION

Meeting 1:
10:45 AM - 11:10 AM

Meeting 2:
11:10 AM - 11:35 AM

Meeting 3:
11:35 AM - 12:00 PM

Lunch Break

12:00 PM - 01:00 PM

Keynote 5

01:00 PM - 01:25 PM

The War on Drugs - Geopolitical Conflict and the Future of Clinical Development

Christopher Bruker

Vice President, Clinical Operations
Affimed

Keynote 6

01:25 PM - 01:50 PM

Strategic outsourcing in clinical trials involves selecting and managing Contract Research Organizations CROs) or Functional Service Providers (FSPs) to enhance efficiency and reduce costs.

Jurate Lasiene

VP of Clinical Operations
NorthSea Therapeutics B.V

Keynote 7

01:50 PM - 02:15 PM

01:50 PM
-
02:15 PM

Regulatory Strategy for Biotech Startups in a Rapidly Evolving Legal Landscape

Dagmara Slaby

Clinical Regulatory Senior Manager
JJP Biologics

CLOSING REMARKS

END OF DAY 2